GLP1R and Hepatic steatosis: We also found that CGA regulated the gut microbiota, improved intestine mucosal barrier, reduced LPS levels, and increased GLP-1, suggesting that CGA could improve hepatic steatosis and inflammation by enhanceing the proportions of beneficial bacteria to increase the level of GLP-1.